Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.

Kefeli, UmutArslan, CagatayYildirim, Mahmut EmreIsikdogan, AbdurrahmanKaradurmus, NuriKarabulut, BulentCubukcu, Erdem2024-06-122024-06-1220210732-183X1527-7755https://doi.org/10.1200/JCO.2021.39.15_suppl.e15561https://hdl.handle.net/20.500.14551/25943Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 04-08, 2021 -- ELECTR NETWORK[Abstract Not Available]en10.1200/JCO.2021.39.15_suppl.e15561info:eu-repo/semantics/closedAccess[No Keywords]Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.Conference Object3915Q1WOS:000708120301226